ResMed, Inc. (RMD)
239.53
+0.64
(+0.27%)
USD |
NYSE |
Nov 13, 16:00
239.53
0.00 (0.00%)
After-Hours: 19:59
ResMed Enterprise Value : 33.18B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 33.18B |
| November 11, 2026 | 33.13B |
| November 10, 2026 | 32.51B |
| November 09, 2026 | 32.74B |
| November 06, 2026 | 32.67B |
| November 05, 2026 | 33.24B |
| November 04, 2026 | 33.41B |
| November 03, 2026 | 31.52B |
| November 02, 2026 | 32.34B |
| October 30, 2026 | 31.92B |
| October 29, 2026 | 35.14B |
| October 28, 2026 | 34.77B |
| October 27, 2026 | 34.85B |
| October 26, 2026 | 35.19B |
| October 23, 2026 | 35.14B |
| October 22, 2026 | 35.17B |
| October 21, 2026 | 34.21B |
| October 20, 2026 | 34.11B |
| October 19, 2026 | 33.30B |
| October 16, 2026 | 33.19B |
| October 15, 2026 | 33.65B |
| October 14, 2026 | 32.67B |
| October 13, 2026 | 32.64B |
| October 12, 2026 | 32.58B |
| October 09, 2026 | 31.94B |
| Date | Value |
|---|---|
| October 08, 2026 | 31.47B |
| October 07, 2026 | 31.36B |
| October 06, 2026 | 30.62B |
| October 05, 2026 | 30.92B |
| October 02, 2026 | 30.37B |
| October 01, 2026 | 30.68B |
| September 30, 2026 | 30.68B |
| September 29, 2026 | 31.49B |
| September 28, 2026 | 31.39B |
| September 25, 2026 | 31.37B |
| September 24, 2026 | 31.36B |
| September 23, 2026 | 31.42B |
| September 22, 2026 | 31.37B |
| September 21, 2026 | 31.61B |
| September 18, 2026 | 31.81B |
| September 17, 2026 | 32.30B |
| September 16, 2026 | 32.28B |
| September 15, 2026 | 32.45B |
| September 14, 2026 | 31.52B |
| September 11, 2026 | 30.84B |
| September 10, 2026 | 31.03B |
| September 09, 2026 | 31.08B |
| September 08, 2026 | 31.24B |
| September 04, 2026 | 32.29B |
| September 03, 2026 | 32.41B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Accuray, Inc. | 102.10M |
| Orthofix Medical, Inc. | 457.96M |
| Rockwell Medical, Inc. | 6.772M |
| Microbot Medical, Inc. | 1.675M |
| Stereotaxis, Inc. | 94.81M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 418.41M |
| Revenue (Quarterly) | 1.415B |
| Total Expenses (Quarterly) | 996.40M |
| EPS Diluted (Quarterly) | 2.918 |
| Gross Profit Margin (Quarterly) | 61.53% |
| Profit Margin (Quarterly) | 29.57% |
| Earnings Yield | 4.58% |
| Operating Earnings Yield | 5.60% |
| Normalized Earnings Yield | 4.632 |